Forget GW Pharmaceuticals: These 2 Stocks Are Better Buys
Yes, GW Pharmaceuticals (NASDAQ: GWPH) is the biggest marijuana-focused biotech stock on the market. The company's promising cannabinoid Epidiolex could very well become a blockbuster success story in the near future in treating children with rare forms of epilepsy. But is GW Pharmaceuticals the best stock to buy right now? No.
Two stocks that could have significantly greater upside, in my view, are Vertex Pharmaceuticals (NASDAQ: VRTX) and Zynerba Pharmaceuticals (NASDAQ: ZYNE). Here's why investors might want to forget about GW Pharmaceuticals and instead buy Vertex and Zynerba.
Image source: Getty Images.
Source: Fool.com
Vertex Pharmaceuticals Inc. Stock
€464.75
0.670%
The stock is one of the favorites of our community with 55 Buy predictions and 2 Sell predictions.
On the other hand, the target price of 450 € is below the current price of 464.75 € for Vertex Pharmaceuticals Inc., so the potential is actually -3.17%.
